Could a common diabetes pill stop prediabetes in its tracks?
NCT ID NCT06828731
Summary
This small, 12-week pilot study tested whether a medication called empagliflozin, which is already used to treat diabetes, could help people with prediabetes. The goal was to see if the drug could slow or prevent the progression to full diabetes and reduce risks for heart and kidney problems. The study involved 60 veterans with prediabetes to check if this approach is practical for future larger trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREDIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Charles George VA Medical Center
Asheville, North Carolina, 28805, United States
Conditions
Explore the condition pages connected to this study.